Levels of Synaptic Proteins in Brain and Neurofilament Light Chain in Cerebrospinal Fluid and Plasma of OVT73 Huntington's Disease Sheep Support a Prodromal Disease State

被引:1
|
作者
Sapp, Ellen [1 ]
Boudi, Adel [1 ]
Reid, Suzanne J. [2 ]
Trombetta, Bianca A. [3 ]
Kivisakk, Pia [3 ]
Taghian, Toloo [4 ,5 ]
Arnold, Steven E. [3 ]
Howland, David [6 ]
Gray-Edwards, Heather
Kegel-Gleason, Kimberly B. [1 ]
DiFiglia, Marian [1 ]
机构
[1] Harvard Med Sch, MassGeneral Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA
[2] Univ Auckland, Sch Biol Sci, Ctr Brain Res, Auckland, New Zealand
[3] Harvard Med Sch, Massachusetts Gen Hosp, Alzheimers Clin & Translat Res Unit, Dept Neurol, Boston, MA USA
[4] Univ Massachusetts, Dept Radiol, Chan Med Sch, Worcester, MA USA
[5] Univ Massachusetts, Horae Gene Therapy Ctr, Chan Med Sch, Worcester, MA USA
[6] CHDI Fdn, CHDI Management, New York, NY USA
关键词
Huntington's disease; HD sheep; caudate; putamen; synaptosomes; neurofilament light chain levels; cerebrospinal fluid; HUMAN MUTANT HUNTINGTIN; POLYGLUTAMINE REPEAT; ANIMAL-MODELS; MOUSE MODEL; EARLY MOTOR; CALMODULIN; PROTEOMICS; REVEALS; MICE;
D O I
10.3233/JHD-230590
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Synaptic changes occur early in patients with Huntington's disease (HD) and in mouse models of HD. An analysis of synaptic changes in HD transgenic sheep (OVT73) is fitting since they have been shown to have some phenotypes. They also have larger brains, longer lifespan, and greater motor and cognitive capacities more aligned with humans, and can provide abundant biofluids for in vivo monitoring of therapeutic interventions. Objective: The objective of this study was to determine if there were differences between 5- and 10-year-old OVT73 and wild-type (WT) sheep in levels of synaptic proteins in brain and in neurofilament light chain (NfL) in cerebrospinal fluid (CSF) and plasma. Methods: Mutant huntingtin (mHTT) and other proteins were measured by western blot assay in synaptosomes prepared from caudate, motor, and piriform cortex in 5-year-old and caudate, putamen, motor; and piriform cortex in 10-year-old WT and OVT73 sheep. Levels of NfL, a biomarker for neuronal damage increased in many neurological disorders including HD, were examined in CSF and plasma samples from 10-year-old WT and OVT73 sheep using the Simoa NfL Advantage kit. Results: Western blot analysis showed mHTT protein expression in synaptosomes from OVT73 sheep was 23% of endogenous sheep HTT levels at both ages. Significant changes were detected in brain levels of PDE10A, SCN4B, DARPP32, calmodulin, SNAP25, PSD95, VGLUT1, VAMP1, and Na+/K+-ATPase, which depended on age and brain region. There was no difference in NfL levels in CSF and plasma in OVT73 sheep compared to age-matched WT sheep. Conclusions: These results show that synaptic changes occur in brain of 5- and 10-year-old OVT73 sheep, but levels of NfL in biofluids are unaffected. Altogether, the data support a prodromal disease state in OVT73 sheep that involves the caudate, putamen and cortex.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 50 条
  • [21] Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease
    Ou, Zhen-Yi Andy
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Tortelli, Rosanna
    Johnson, Eileanoir B.
    Foiani, Martha S.
    Arridge, Marzena
    De Vita, Enrico
    Scahill, Rachael I.
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
    Zhen-Yi Andy Ou
    Lauren M. Byrne
    Filipe B. Rodrigues
    Rosanna Tortelli
    Eileanoir B. Johnson
    Martha S. Foiani
    Marzena Arridge
    Enrico De Vita
    Rachael I. Scahill
    Amanda Heslegrave
    Henrik Zetterberg
    Edward J. Wild
    Scientific Reports, 11
  • [23] Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data
    Hwang, Yun Su
    Oh, Eungseok
    Kim, Manho
    Lee, Chan Young
    Kim, Hyun Sook
    Chung, Sun Ju
    Sung, Young Hee
    Yoon, Won Tae
    Cho, Jin Hwan
    Lee, Jae-Hyeok
    Kim, Han-Joon
    Chang, Hee Jin
    Jeon, Beomseok
    Woo, Kyung Ah.
    Ko, Seong Beom
    Kwon, Kyum-Yil
    Moon, Jangsup
    Shin, Chaewon
    Kim, Young Eun
    Lee, Jee-Young
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 452
  • [24] Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson’s disease
    Weifang Yin
    Yongyun Zhu
    Baiyuan Yang
    Fang Wang
    Kangfu Yin
    Chuanbin Zhou
    Hui Ren
    Xinglong Yang
    Neurological Sciences, 2022, 43 : 2839 - 2843
  • [25] Correlation between levels of plasma neurofilament light chain and freezing of gait in Parkinson's disease
    Zhu, Y.
    Yang, X.
    Ren, H.
    Pang, A.
    MOVEMENT DISORDERS, 2023, 38 : S574 - S575
  • [26] Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson's disease
    Yin, Weifang
    Zhu, Yongyun
    Yang, Baiyuan
    Wang, Fang
    Yin, Kangfu
    Zhou, Chuanbin
    Ren, Hui
    Yang, Xinglong
    NEUROLOGICAL SCIENCES, 2022, 43 (04) : 2839 - 2843
  • [27] Cerebrospinal fluid and blood levels of neurofilament light chain in Parkinson disease A protocol for systematic review and meta-analysis
    Wang, HongZhou
    Wang, WanHua
    Shi, HaiCun
    Han, LiJian
    Pan, PingLei
    MEDICINE, 2020, 99 (31) : E21458
  • [28] Neurofilament light chain levels in cerebrospinal fluid and serum of a longitudinal cohort of people with multiple sclerosis on disease modifying drugs
    Bianchi, L.
    Baker, D.
    Giovannoni, G.
    Marta, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 734 - 735
  • [29] Brain-Derived Neurotrophic Factor in Cerebrospinal Fluid and Plasma as a Potential Biomarker for Huntington's Disease
    Ou, Zhen-Yi Andy
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Tortelli, Rosanna
    Johnson, Eileanor B.
    Foiani, Martha S.
    Arridge, Marzena
    De Vita, Enrico
    Scahill, Rachael I.
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward J.
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1373 - 1374
  • [30] Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease
    Targa, Adriano
    Dakterzada, Faride
    Benitez, Ivan
    Lopez, Ricard
    Pujol, Montserrat
    Dalmases, Mireia
    Arias, Alfonso
    Sanchez-de-la-Torre, Manuel
    Zetterberg, Henrik
    Blennow, Kaj
    Pamplona, Reinald
    Jove, Mariona
    Barbe, Ferran
    Pinol-Ripoll, Gerard
    SLEEP, 2021, 44 (02)